Wenlong Nie

Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Corrigendum to "N-acetylcysteine and chitosan conjugate modified dexamethasone nanostructured lipid carriers: Enhanced permeability, precorneal retention and lower inflammation for the treatment of dry eye syndrome" [International Journal of Biological Macromolecules 299 (2025) 140123].

Corrigendum to "N-acetylcysteine and chitosan conjugate modified dexamethasone nanostructured lipid carriers: Enhanced permeability, precorneal retention and lower inflammation for the treatment of dry eye syndrome" [International Journal of Biological Macromolecules 299 (2025) 140123].

Journal: International journal of biological macromolecules

Published: June 03, 2026

Farnesoid X receptor deficiency accelerates aging and systemic functional decline in male mice.

Farnesoid X receptor deficiency accelerates aging and systemic functional decline in male mice.

Journal: Biogerontology

Published: January 27, 2026

Enhanced paclitaxel oral delivery by astragalus polysaccharide-based nanoplatform for triple-negative breast cancer treatment.

Enhanced paclitaxel oral delivery by astragalus polysaccharide-based nanoplatform for triple-negative breast cancer treatment.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: January 17, 2026

Zhimu-Huangbai codecoction for the treatment of type II diabetes mellitus through its self-assembling nanoparticles.

Zhimu-Huangbai codecoction for the treatment of type II diabetes mellitus through its self-assembling nanoparticles.

Journal: Chinese medicine

Published: September 15, 2025

Astragalus polysaccharide-based nano-platforms loading PTX to boost chemo-immunotherapy for triple-negative breast cancer with intrinsic GLUT-targeting ability and immunoregulatory activity.

Astragalus polysaccharide-based nano-platforms loading PTX to boost chemo-immunotherapy for triple-negative breast cancer with intrinsic GLUT-targeting ability and immunoregulatory activity.

Journal: Journal of nanobiotechnology

Published: June 16, 2025

Activation of Nuclear Receptor CAR: A Pathway to Delay Aging through Enhanced Capacity for Xenobiotic Resistance.

Activation of Nuclear Receptor CAR: A Pathway to Delay Aging through Enhanced Capacity for Xenobiotic Resistance.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 13, 2024

N-acetylcysteine and chitosan conjugate modified dexamethasone nanostructured lipid carriers: Enhanced permeability, precorneal retention and lower inflammation for the treatment of dry eye syndrome.

N-acetylcysteine and chitosan conjugate modified dexamethasone nanostructured lipid carriers: Enhanced permeability, precorneal retention and lower inflammation for the treatment of dry eye syndrome.

Journal: International journal of biological macromolecules

Published: December 04, 2024

Tumor-targeted nanosystem with hypoxia inducible factor 1α inhibition for synergistic chemo-photodynamic therapy against hypoxic tumor.

Tumor-targeted nanosystem with hypoxia inducible factor 1α inhibition for synergistic chemo-photodynamic therapy against hypoxic tumor.

Journal: Colloids and surfaces. B, Biointerfaces

Published: September 11, 2024

Exploring the influence of polysaccharide on gastrointestinal stability, drug release and formation mechanism of nanoparticles in Zhimu and Huangbai herb pair decoction.

Exploring the influence of polysaccharide on gastrointestinal stability, drug release and formation mechanism of nanoparticles in Zhimu and Huangbai herb pair decoction.

Journal: Scientific reports

Published: July 22, 2024

Advancements in nano drug delivery system for liver cancer therapy based on mitochondria-targeting.

Advancements in nano drug delivery system for liver cancer therapy based on mitochondria-targeting.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 10, 2024

Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c.

Zhimu-Huangbai herb-pair ameliorates hepatic steatosis in mice by regulating IRE1α/XBP1s pathway to inhibit SREBP-1c.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 01, 2024

Self-Assembled Nanoparticles from Xie-Bai-San Decoction: Isolation, Characterization and Enhancing Oral Bioavailability.

Self-Assembled Nanoparticles from Xie-Bai-San Decoction: Isolation, Characterization and Enhancing Oral Bioavailability.

Journal: International journal of nanomedicine

Published: November 10, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026